Koshkin, V. S., et al. Prognostic value of CD56, ASCL1, and other biomarkers in small cell bladder cancer (SCBC). Poster session presented at: 2018 Genitourinary Cancers Symposium; 2018 Feb 9; San Francisco, CA. J Clin Oncol 36, 2018 (suppl 6S; abstr 452).
Finn, R. S. et al. Comprehensive Gene Expression Biomarker Analysis of Cyclin-Dependent Kinases 4/6 and Endocrine Pathways From the PALOMA-2 Study. Poster session presented at: San Antonio Breast Cancer Symposium (SABC); 2017 Dec 5-9; San Antonio, TX.
Mian O., et al. Molecular profiling of small cell bladder cancer (SCBC) to reveal gene expression determinants of an aggressive phenotype. Poster presented at: The American Society of Clinical Oncology (ASCO), 2017 Jun; Chicago, IL
Sunakawa, Y., et al. Association of gene signature to identify molecular subtypes with clinical outcomes of 1st-line cetuximab (cet) treatment for metastatic colorectal cancer (mCRC). J Clin Oncol. 2016;34(Suppl):abstr 3592.
Margolles Clark E., et al. Gene expression profiling of transplant formalin-fixed, paraffin-embedded biopsies: comparison of a custom TaqMan low density array and quantitative nuclease-protection assay. Hum Immunol. 2016 Sep;77(Suppl):74.
Lo B., et al. Combining Automated Tissue Dissection with Extraction Free Nucleic Acid Analysis. J Mol Diag. 2016, 18: 1048.
Lipchik C., et al. FFPE Tissue and the HTG Oncology Biomarker Panel: Low-Input, Extraction-Free Gene Expression Pilot Study. Poster session presented at: The Mid-Atlantic Directors and Staff of Scientific Cores; 2016; Pittsburgh, PA.
Reinholz M., et. al. The HTG EdgeSeq Oncology Biomarker Panel enables NGS-based gene expression profiling from small samples. Poster presented at: Association of Biomedical Research Cores; 2016 Feb 20-23; Ft Lauderdale, FL
Page last updated May 22, 2023